These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8969322)

  • 1. Synthesizing evidence from multiple studies. The role of meta-analysis in pharmacoeconomics.
    Lafata JE; Koch GG; Ward RE
    Med Care; 1996 Dec; 34(12 Suppl):DS136-45. PubMed ID: 8969322
    [No Abstract]   [Full Text] [Related]  

  • 2. Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2.
    Hoaglin DC; Hawkins N; Jansen JP; Scott DA; Itzler R; Cappelleri JC; Boersma C; Thompson D; Larholt KM; Diaz M; Barrett A
    Value Health; 2011 Jun; 14(4):429-37. PubMed ID: 21669367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of pharmacoeconomics analyses to health protection].
    Drozd M
    Wiad Lek; 2002; 55 Suppl 1():76-9. PubMed ID: 15002222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacoeconomics of dementia.
    Whitehouse PJ
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 5():S22-32; discussion S32-3. PubMed ID: 9348424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacoeconomics in contemporary medicine].
    Czech M
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():16-9. PubMed ID: 15524007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacoeconomics.
    Ahuja J; Gupta M; Gupta AK; Kohli K
    Natl Med J India; 2004; 17(2):80-3. PubMed ID: 15141600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis: when and how.
    Imperiale TF
    Hepatology; 1999 Jun; 29(6 Suppl):26S-31S. PubMed ID: 10386080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there a need for standardization of methods in economic evaluations of medicine?
    Rittenhouse BE
    Med Care; 1996 Dec; 34(12 Suppl):DS13-22. PubMed ID: 8969311
    [No Abstract]   [Full Text] [Related]  

  • 9. Guidelines for pharmacoeconomic and outcomes research fellowship training programs: joint guidelines from the american college of clinical pharmacy and the international society of pharmacoeconomics and outcomes research.
    Kane-Gill S; Reddy P; Gupta SR; Bakst AW
    Pharmacotherapy; 2008 Dec; 28(12):1552. PubMed ID: 19025439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of pharmacoeconomics in prescribing research. Part 4: is cost-utility analysis a useful tool?
    Brinsmead R; Hill S
    J Clin Pharm Ther; 2003 Aug; 28(4):339-46. PubMed ID: 12911687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacoeconomics: integrating economic evaluation into clinical trials.
    Haycox A; Drummond M; Walley T
    Br J Clin Pharmacol; 1997 Jun; 43(6):559-62. PubMed ID: 9205814
    [No Abstract]   [Full Text] [Related]  

  • 12. Classic or Bayesian research design and analysis. Does it make a difference?
    Bloom BS; de Pouvourville N; Libert S
    Int J Technol Assess Health Care; 2002; 18(1):120-6. PubMed ID: 11987435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relevance of pharmacoeconomic analyses to price and reimbursement decisions in Austria].
    Führlinger S
    Wien Med Wochenschr; 2006 Dec; 156(23-24):612-8. PubMed ID: 17211765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis: apples and oranges, or fruitless.
    Vatz JB
    Physician Exec; 1991; 17(3):40-2. PubMed ID: 10111673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacoeconomics and immunotherapy.
    Berto P
    Eur Ann Allergy Clin Immunol; 2007; 39 Spec No():12-6. PubMed ID: 18924461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesizing the evidence: how far can your confidence meter take you?
    Fineout-Overholt E
    AACN Adv Crit Care; 2008; 19(3):335-9. PubMed ID: 18670209
    [No Abstract]   [Full Text] [Related]  

  • 17. Conjoint analysis applications in health--a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force.
    Bridges JF; Hauber AB; Marshall D; Lloyd A; Prosser LA; Regier DA; Johnson FR; Mauskopf J
    Value Health; 2011 Jun; 14(4):403-13. PubMed ID: 21669364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Putting the practice into evidence-based dentistry.
    Coulter ID
    J Calif Dent Assoc; 2007 Jan; 35(1):45-9. PubMed ID: 17269287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commentary: pharmacoeconomics and outcomes research: expanding the healthcare "outcomes" market.
    Hay JW; Yu WM
    Value Health; 2000; 3(3):181-5. PubMed ID: 16464182
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluating the quality of published pharmacoeconomic evaluations.
    Sanchez LA
    Hosp Pharm; 1995 Feb; 30(2):146-8, 151-2. PubMed ID: 10140528
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.